Proactiveinvestors USA & Canada ANGLE PLC https://ca.proactiveinvestors.com Proactiveinvestors USA & Canada ANGLE PLC RSS feed en Thu, 05 Dec 2019 22:37:39 -0500 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) ANGLE says leading European cancer centre work demonstrates Parsortix can be used as liquid biopsy for melanoma patients https://ca.proactiveinvestors.com/companies/news/906501/angle-says-leading-european-cancer-centre-work-demonstrates-parsortix-can-be-used-as-liquid-biopsy-for-melanoma-patients-906501.html Thu, 07 Nov 2019 08:10:00 -0500 https://ca.proactiveinvestors.com/companies/news/906501/angle-says-leading-european-cancer-centre-work-demonstrates-parsortix-can-be-used-as-liquid-biopsy-for-melanoma-patients-906501.html ANGLE’s Parsortix liquid biopsy proving to be more than just a cancer detection device https://ca.proactiveinvestors.com/companies/news/211923/angles-parsortix-liquid-biopsy-proving-to-be-more-than-just-a-cancer-detection-device-211923.html Wed, 30 Oct 2019 15:20:00 -0400 https://ca.proactiveinvestors.com/companies/news/211923/angles-parsortix-liquid-biopsy-proving-to-be-more-than-just-a-cancer-detection-device-211923.html ANGLE PLC submits its flagship Parsortix liquid biopsy diagnostic to the FDA https://ca.proactiveinvestors.com/companies/news/905921/angle-plc-submits-its-flagship-parsortix-liquid-biopsy-diagnostic-to-the-fda-905921.html Wed, 30 Oct 2019 09:28:00 -0400 https://ca.proactiveinvestors.com/companies/news/905921/angle-plc-submits-its-flagship-parsortix-liquid-biopsy-diagnostic-to-the-fda-905921.html ANGLE predicts FDA clearance of Parsortix in third quarter of 2020 https://ca.proactiveinvestors.com/companies/news/905909/angle-predicts-fda-clearance-of-parsortix-in-third-quarter-of-2020-905909.html Wed, 30 Oct 2019 08:20:00 -0400 https://ca.proactiveinvestors.com/companies/news/905909/angle-predicts-fda-clearance-of-parsortix-in-third-quarter-of-2020-905909.html ANGLE says Queen Mary University patent could pave the way for a new use for its technology https://ca.proactiveinvestors.com/companies/news/904157/angle-says-queen-mary-university-patent-could-pave-the-way-for-a-new-use-for-its-technology-904157.html Fri, 04 Oct 2019 06:29:00 -0400 https://ca.proactiveinvestors.com/companies/news/904157/angle-says-queen-mary-university-patent-could-pave-the-way-for-a-new-use-for-its-technology-904157.html Investor update: ANGLE PLC sees head and neck cancer potential for its liquid biopsy https://ca.proactiveinvestors.com/companies/news/902663/investor-update-angle-plc-sees-head-and-neck-cancer-potential-for-its-liquid-biopsy-902663.html Fri, 13 Sep 2019 07:57:00 -0400 https://ca.proactiveinvestors.com/companies/news/902663/investor-update-angle-plc-sees-head-and-neck-cancer-potential-for-its-liquid-biopsy-902663.html ANGLE review points to liquid biopsy's potential to guide head and neck cancer treatment https://ca.proactiveinvestors.com/companies/news/902653/angle-review-points-to-liquid-biopsy-s-potential-to-guide-head-and-neck-cancer-treatment-902653.html Fri, 13 Sep 2019 06:27:00 -0400 https://ca.proactiveinvestors.com/companies/news/902653/angle-review-points-to-liquid-biopsy-s-potential-to-guide-head-and-neck-cancer-treatment-902653.html ANGLE’s Parsortix demonstrates potential to out-perform current standards for prostate cancer detection https://ca.proactiveinvestors.com/companies/news/902358/angles-parsortix-demonstrates-potential-to-out-perform-current-standards-for-prostate-cancer-detection-902358.html Tue, 10 Sep 2019 06:52:00 -0400 https://ca.proactiveinvestors.com/companies/news/902358/angles-parsortix-demonstrates-potential-to-out-perform-current-standards-for-prostate-cancer-detection-902358.html Anglesey Mining mulls longer mine life and production rate at Parys Mountain https://ca.proactiveinvestors.com/companies/news/902113/anglesey-mining-mulls-longer-mine-life-and-production-rate-at-parys-mountain-902113.html Thu, 05 Sep 2019 11:31:00 -0400 https://ca.proactiveinvestors.com/companies/news/902113/anglesey-mining-mulls-longer-mine-life-and-production-rate-at-parys-mountain-902113.html ANGLE’s Parsortix system could help “significantly improve” diagnosis and treatment of lung cancer https://ca.proactiveinvestors.com/companies/news/902004/angles-parsortix-system-could-help-significantly-improve-diagnosis-and-treatment-of-lung-cancer-902004.html Wed, 04 Sep 2019 06:56:00 -0400 https://ca.proactiveinvestors.com/companies/news/902004/angles-parsortix-system-could-help-significantly-improve-diagnosis-and-treatment-of-lung-cancer-902004.html ANGLE PLC ovarian cancer study gets underway https://ca.proactiveinvestors.com/companies/news/901689/angle-plc-ovarian-cancer-study-gets-underway-901689.html Thu, 29 Aug 2019 06:46:00 -0400 https://ca.proactiveinvestors.com/companies/news/901689/angle-plc-ovarian-cancer-study-gets-underway-901689.html ANGLE still 'on track' for FDA submission of Parsortix cancer-detecting system this year https://ca.proactiveinvestors.com/companies/news/224785/angle-still--on-track--for-fda-submission-of-parsortix-cancer-detecting-system-this-year-224785.html Wed, 31 Jul 2019 09:10:00 -0400 https://ca.proactiveinvestors.com/companies/news/224785/angle-still--on-track--for-fda-submission-of-parsortix-cancer-detecting-system-this-year-224785.html ANGLE liquid biopsy used in German breast cancer study https://ca.proactiveinvestors.com/companies/news/224258/angle-liquid-biopsy-used-in-german-breast-cancer-study-224258.html Mon, 22 Jul 2019 10:28:00 -0400 https://ca.proactiveinvestors.com/companies/news/224258/angle-liquid-biopsy-used-in-german-breast-cancer-study-224258.html ANGLE raises £18mln as it gears up for Parsortix commercialisation https://ca.proactiveinvestors.com/companies/news/222752/angle-raises-18mln-as-it-gears-up-for-parsortix-commercialisation-222752.html Tue, 25 Jun 2019 13:20:00 -0400 https://ca.proactiveinvestors.com/companies/news/222752/angle-raises-18mln-as-it-gears-up-for-parsortix-commercialisation-222752.html ANGLE sees the potential to use its liquid biopsy system in cancer clinical trials https://ca.proactiveinvestors.com/companies/news/222563/angle-sees-the-potential-to-use-its-liquid-biopsy-system-in-cancer-clinical-trials-222563.html Fri, 21 Jun 2019 06:55:00 -0400 https://ca.proactiveinvestors.com/companies/news/222563/angle-sees-the-potential-to-use-its-liquid-biopsy-system-in-cancer-clinical-trials-222563.html ANGLE scores early success in ovarian cancer study https://ca.proactiveinvestors.com/companies/news/221524/angle-scores-early-success-in-ovarian-cancer-study-221524.html Wed, 05 Jun 2019 10:30:00 -0400 https://ca.proactiveinvestors.com/companies/news/221524/angle-scores-early-success-in-ovarian-cancer-study-221524.html ANGLE device could receive US regulatory sign-off early next year after breast cancer trial success https://ca.proactiveinvestors.com/companies/news/221275/angle-device-could-receive-us-regulatory-sign-off-early-next-year-after-breast-cancer-trial-success-221275.html Fri, 31 May 2019 06:23:00 -0400 https://ca.proactiveinvestors.com/companies/news/221275/angle-device-could-receive-us-regulatory-sign-off-early-next-year-after-breast-cancer-trial-success-221275.html ANGLE PLC - Proactive One2One investor forum May 2019 https://ca.proactiveinvestors.com/companies/news/313484/angle-plc---proactive-one2one-investor-forum-may-2019-13484.html Fri, 24 May 2019 14:26:00 -0400 https://ca.proactiveinvestors.com/companies/news/313484/angle-plc---proactive-one2one-investor-forum-may-2019-13484.html ANGLE device aids ground-breaking research on cancer spread https://ca.proactiveinvestors.com/companies/news/219151/angle-device-aids-ground-breaking-research-on-cancer-spread-219151.html Fri, 26 Apr 2019 14:25:00 -0400 https://ca.proactiveinvestors.com/companies/news/219151/angle-device-aids-ground-breaking-research-on-cancer-spread-219151.html ANGLE's Parsortix device plays critical role in ground-breaking research on cancer spread https://ca.proactiveinvestors.com/companies/news/313114/angle-s-parsortix-device-plays-critical-role-in-ground-breaking-research-on-cancer-spread-13114.html Fri, 26 Apr 2019 10:15:00 -0400 https://ca.proactiveinvestors.com/companies/news/313114/angle-s-parsortix-device-plays-critical-role-in-ground-breaking-research-on-cancer-spread-13114.html ANGLE shares rise 11% after its tumour cell detection device is deployed in cancer advance https://ca.proactiveinvestors.com/companies/news/218824/angle-shares-rise-11-after-its-tumour-cell-detection-device-is-deployed-in-cancer-advance-218824.html Thu, 18 Apr 2019 12:32:00 -0400 https://ca.proactiveinvestors.com/companies/news/218824/angle-shares-rise-11-after-its-tumour-cell-detection-device-is-deployed-in-cancer-advance-218824.html ANGLE ground-breaking liquid biopsy to be used in lung cancer study https://ca.proactiveinvestors.com/companies/news/218472/angle-ground-breaking-liquid-biopsy-to-be-used-in-lung-cancer-study-218472.html Fri, 12 Apr 2019 14:55:00 -0400 https://ca.proactiveinvestors.com/companies/news/218472/angle-ground-breaking-liquid-biopsy-to-be-used-in-lung-cancer-study-218472.html ANGLE’s Parsortix liquid biopsy getting lots of exposure at world’s biggest cancer conference https://ca.proactiveinvestors.com/companies/news/217938/angles-parsortix-liquid-biopsy-getting-lots-of-exposure-at-worlds-biggest-cancer-conference-217938.html Thu, 04 Apr 2019 06:40:00 -0400 https://ca.proactiveinvestors.com/companies/news/217938/angles-parsortix-liquid-biopsy-getting-lots-of-exposure-at-worlds-biggest-cancer-conference-217938.html ANGLE passes key milestone recruitment is completed for phase III clinical trial of its liquid biopsy system https://ca.proactiveinvestors.com/companies/news/215973/angle-passes-key-milestone-recruitment-is-completed-for-phase-iii-clinical-trial-of-its-liquid-biopsy-system-215973.html Thu, 07 Mar 2019 07:34:00 -0500 https://ca.proactiveinvestors.com/companies/news/215973/angle-passes-key-milestone-recruitment-is-completed-for-phase-iii-clinical-trial-of-its-liquid-biopsy-system-215973.html “Significant milestone” for ANGLE as it kicks off second ovarian cancer study https://ca.proactiveinvestors.com/companies/news/215497/significant-milestone-for-angle-as-it-kicks-off-second-ovarian-cancer-study-215497.html Thu, 28 Feb 2019 08:19:00 -0500 https://ca.proactiveinvestors.com/companies/news/215497/significant-milestone-for-angle-as-it-kicks-off-second-ovarian-cancer-study-215497.html ANGLE: Researchers find new use for company's cancer cell harvesting device https://ca.proactiveinvestors.com/companies/news/215192/angle-researchers-find-new-use-for-company-s-cancer-cell-harvesting-device-215192.html Mon, 25 Feb 2019 07:57:00 -0500 https://ca.proactiveinvestors.com/companies/news/215192/angle-researchers-find-new-use-for-company-s-cancer-cell-harvesting-device-215192.html ANGLE technology used in cutting-edge research featured in science journal Nature https://ca.proactiveinvestors.com/companies/news/214337/angle-technology-used-in-cutting-edge-research-featured-in-science-journal-nature-214337.html Mon, 11 Feb 2019 07:56:00 -0500 https://ca.proactiveinvestors.com/companies/news/214337/angle-technology-used-in-cutting-edge-research-featured-in-science-journal-nature-214337.html ANGLE on track to complete key Parsortix study in current quarter https://ca.proactiveinvestors.com/companies/news/213690/angle-on-track-to-complete-key-parsortix-study-in-current-quarter-213690.html Thu, 31 Jan 2019 08:00:00 -0500 https://ca.proactiveinvestors.com/companies/news/213690/angle-on-track-to-complete-key-parsortix-study-in-current-quarter-213690.html ANGLE device has lymph node potential, says German research team https://ca.proactiveinvestors.com/companies/news/213485/angle--device-has-lymph-node-potential-says-german-research-team-213485.html Tue, 29 Jan 2019 11:22:00 -0500 https://ca.proactiveinvestors.com/companies/news/213485/angle--device-has-lymph-node-potential-says-german-research-team-213485.html ANGLE plc's Parsortix device plays critical role in ground-breaking new cancer research https://ca.proactiveinvestors.com/companies/news/311799/angle-plc-s-parsortix-device-plays-critical-role-in-ground-breaking-new-cancer-research-11799.html Fri, 11 Jan 2019 13:03:00 -0500 https://ca.proactiveinvestors.com/companies/news/311799/angle-plc-s-parsortix-device-plays-critical-role-in-ground-breaking-new-cancer-research-11799.html ANGLE device central to new, ground-breaking cancer research https://ca.proactiveinvestors.com/companies/news/212375/angle-device-central-to-new-ground-breaking-cancer-research-212375.html Fri, 11 Jan 2019 07:28:00 -0500 https://ca.proactiveinvestors.com/companies/news/212375/angle-device-central-to-new-ground-breaking-cancer-research-212375.html ANGLE names diagnostic pathology expert Dr Joseph D Khoury as a scientific advisor https://ca.proactiveinvestors.com/companies/news/210093/angle-names-diagnostic-pathology-expert-dr-joseph-d-khoury-as-a-scientific-advisor-210093.html Wed, 28 Nov 2018 07:31:00 -0500 https://ca.proactiveinvestors.com/companies/news/210093/angle-names-diagnostic-pathology-expert-dr-joseph-d-khoury-as-a-scientific-advisor-210093.html ANGLE acquires remaining stake in US subsidiary from Parsortix inventor https://ca.proactiveinvestors.com/companies/news/208492/angle-acquires-remaining-stake-in-us-subsidiary-from-parsortix-inventor-208492.html Mon, 05 Nov 2018 08:34:00 -0500 https://ca.proactiveinvestors.com/companies/news/208492/angle-acquires-remaining-stake-in-us-subsidiary-from-parsortix-inventor-208492.html ANGLE finds a new angle for cancer detection device as it screens pregnant women https://ca.proactiveinvestors.com/companies/news/207996/angle-finds-a-new-angle-for-cancer-detection-device-as-it-screens-pregnant-women-207996.html Mon, 29 Oct 2018 15:12:00 -0400 https://ca.proactiveinvestors.com/companies/news/207996/angle-finds-a-new-angle-for-cancer-detection-device-as-it-screens-pregnant-women-207996.html ANGLE PLC sees big opportunities in non-invasive prenatal testing https://ca.proactiveinvestors.com/companies/news/311017/angle-plc-sees-big-opportunities-in-non-invasive-prenatal-testing-11017.html Mon, 29 Oct 2018 10:52:00 -0400 https://ca.proactiveinvestors.com/companies/news/311017/angle-plc-sees-big-opportunities-in-non-invasive-prenatal-testing-11017.html Over 75% of patients now enrolled into ANGLE’s Parsortix clinical study https://ca.proactiveinvestors.com/companies/news/207826/over-75-of-patients-now-enrolled-into-angles-parsortix-clinical-study-207826.html Thu, 25 Oct 2018 07:27:00 -0400 https://ca.proactiveinvestors.com/companies/news/207826/over-75-of-patients-now-enrolled-into-angles-parsortix-clinical-study-207826.html Scientists make major breakthrough with ANGLE’s Parsortix liquid biopsy system https://ca.proactiveinvestors.com/companies/news/203676/scientists-make-major-breakthrough-with-angles-parsortix-liquid-biopsy-system-203676.html Tue, 28 Aug 2018 07:18:00 -0400 https://ca.proactiveinvestors.com/companies/news/203676/scientists-make-major-breakthrough-with-angles-parsortix-liquid-biopsy-system-203676.html ANGLE on track to conclude FDA study by year-end https://ca.proactiveinvestors.com/companies/news/201511/angle-on-track-to-conclude-fda-study-by-year-end-201511.html Wed, 25 Jul 2018 06:37:00 -0400 https://ca.proactiveinvestors.com/companies/news/201511/angle-on-track-to-conclude-fda-study-by-year-end-201511.html finnCap retains 110p target price on ANGLE in the wake of 50p per share placing which raised £12.7mln https://ca.proactiveinvestors.com/companies/news/199608/finncap-retains-110p-target-price-on-angle-in-the-wake-of-50p-per-share-placing-which-raised-127mln-199608.html Tue, 26 Jun 2018 14:39:00 -0400 https://ca.proactiveinvestors.com/companies/news/199608/finncap-retains-110p-target-price-on-angle-in-the-wake-of-50p-per-share-placing-which-raised-127mln-199608.html ANGLE announces new share placing in £12mln fundraise https://ca.proactiveinvestors.com/companies/news/199476/angle-announces-new-share-placing-in-12mln-fundraise-199476.html Mon, 25 Jun 2018 08:21:00 -0400 https://ca.proactiveinvestors.com/companies/news/199476/angle-announces-new-share-placing-in-12mln-fundraise-199476.html Liquid biopsies: The breakthrough cancer tests which AIM-listed ANGLE is already developing https://ca.proactiveinvestors.com/companies/news/198198/liquid-biopsies-the-breakthrough-cancer-tests-which-aim-listed-angle-is-already-developing-198198.html Mon, 04 Jun 2018 13:15:00 -0400 https://ca.proactiveinvestors.com/companies/news/198198/liquid-biopsies-the-breakthrough-cancer-tests-which-aim-listed-angle-is-already-developing-198198.html ANGLE clinical study making encouraging progress https://ca.proactiveinvestors.com/companies/news/198154/angle-clinical-study-making-encouraging-progress-198154.html Mon, 04 Jun 2018 06:16:00 -0400 https://ca.proactiveinvestors.com/companies/news/198154/angle-clinical-study-making-encouraging-progress-198154.html ANGLE appoints leading prostate cancer surgeon Greg Shaw as scientific advisor https://ca.proactiveinvestors.com/companies/news/196880/ANGLE-appoints-leading-prostate-cancer-surgeon-Greg-Shaw-as-scientific-advisor-196880.html Mon, 14 May 2018 06:34:00 -0400 https://ca.proactiveinvestors.com/companies/news/196880/ANGLE-appoints-leading-prostate-cancer-surgeon-Greg-Shaw-as-scientific-advisor-196880.html ANGLE upbeat on QIAGEN collaboration ahead of poster presentation https://ca.proactiveinvestors.com/companies/news/196317/angle-upbeat-on-qiagen-collaboration-ahead-of-poster-presentation-196317.html Thu, 03 May 2018 06:57:00 -0400 https://ca.proactiveinvestors.com/companies/news/196317/angle-upbeat-on-qiagen-collaboration-ahead-of-poster-presentation-196317.html ANGLE higher as researchers may have found new “high value application” for breakthrough cancer cell capture system https://ca.proactiveinvestors.com/companies/news/195336/angle-higher-as-researchers-may-have-found-new-high-value-application-for-breakthrough-cancer-cell-capture-system-195336.html Thu, 19 Apr 2018 12:00:00 -0400 https://ca.proactiveinvestors.com/companies/news/195336/angle-higher-as-researchers-may-have-found-new-high-value-application-for-breakthrough-cancer-cell-capture-system-195336.html ANGLE PLC's Andrew Newland on 'breakthrough in culturing CTCs' https://ca.proactiveinvestors.com/companies/news/309107/angle-plc-s-andrew-newland-on-breakthrough-in-culturing-ctcs--9107.html Thu, 19 Apr 2018 11:51:00 -0400 https://ca.proactiveinvestors.com/companies/news/309107/angle-plc-s-andrew-newland-on-breakthrough-in-culturing-ctcs--9107.html ANGLE aiming for world first as patient enrolled in clinical study for Parsortix system https://ca.proactiveinvestors.com/companies/news/194312/angle-aiming-for-world-first-as-patient-enrolled-in-clinical-study-for-parsortix-system-194312.html Thu, 05 Apr 2018 06:57:00 -0400 https://ca.proactiveinvestors.com/companies/news/194312/angle-aiming-for-world-first-as-patient-enrolled-in-clinical-study-for-parsortix-system-194312.html ANGLE presents detailed results of ovarian study to US cancer group https://ca.proactiveinvestors.com/companies/news/193769/angle-presents-detailed-results-of-ovarian-study-to-us-cancer-group-193769.html Mon, 26 Mar 2018 07:14:00 -0400 https://ca.proactiveinvestors.com/companies/news/193769/angle-presents-detailed-results-of-ovarian-study-to-us-cancer-group-193769.html ANGLE PLC opens up potential route to market for Parsortix platform https://ca.proactiveinvestors.com/companies/news/308708/angle-plc-opens-up-potential-route-to-market-for-parsortix-platform-8708.html Tue, 06 Feb 2018 12:53:00 -0500 https://ca.proactiveinvestors.com/companies/news/308708/angle-plc-opens-up-potential-route-to-market-for-parsortix-platform-8708.html ANGLE to collaborate with Abbott Laboratories on metastatic breast cancer study https://ca.proactiveinvestors.com/companies/news/191196/angle-to-collaborate-with-abbott-laboratories-on-metastatic-breast-cancer-study-191196.html Tue, 06 Feb 2018 07:38:00 -0500 https://ca.proactiveinvestors.com/companies/news/191196/angle-to-collaborate-with-abbott-laboratories-on-metastatic-breast-cancer-study-191196.html ANGLE making "excellent progress", says chairman https://ca.proactiveinvestors.com/companies/news/190880/angle-making-excellent-progress-says-chairman-190880.html Wed, 31 Jan 2018 13:48:00 -0500 https://ca.proactiveinvestors.com/companies/news/190880/angle-making-excellent-progress-says-chairman-190880.html Leading professor to host webinar on ANGLE’s Parsortix system https://ca.proactiveinvestors.com/companies/news/190078/leading-professor-to-host-webinar-on-angles-parsortix-system-190078.html Tue, 16 Jan 2018 08:02:00 -0500 https://ca.proactiveinvestors.com/companies/news/190078/leading-professor-to-host-webinar-on-angles-parsortix-system-190078.html ANGLE's blood biopsy could aid the treatment of patients with late-stage prostate cancer https://ca.proactiveinvestors.com/companies/news/189630/angle-s-blood-biopsy-could-aid-the-treatment-of-patients-with-late-stage-prostate-cancer-189630.html Mon, 08 Jan 2018 07:31:00 -0500 https://ca.proactiveinvestors.com/companies/news/189630/angle-s-blood-biopsy-could-aid-the-treatment-of-patients-with-late-stage-prostate-cancer-189630.html ANGLE's Parsortix device could revolutionise breast cancer treatment https://ca.proactiveinvestors.com/companies/news/188493/angle-s-parsortix-device-could-revolutionise-breast-cancer-treatment-188493.html Fri, 08 Dec 2017 08:29:00 -0500 https://ca.proactiveinvestors.com/companies/news/188493/angle-s-parsortix-device-could-revolutionise-breast-cancer-treatment-188493.html ANGLE: Vienna study reveals key advantage of company's blood biopsy https://ca.proactiveinvestors.com/companies/news/187883/angle-vienna-study-reveals-key-advantage-of-company-s-blood-biopsy-187883.html Tue, 28 Nov 2017 07:58:00 -0500 https://ca.proactiveinvestors.com/companies/news/187883/angle-vienna-study-reveals-key-advantage-of-company-s-blood-biopsy-187883.html Dutch healthcare and electronics giant Philips to use ANGLE’s Parsortix system as part of four-year collaboration https://ca.proactiveinvestors.com/companies/news/187695/dutch-healthcare-and-electronics-giant-philips-to-use-angles-parsortix-system-as-part-of-four-year-collaboration-187695.html Thu, 23 Nov 2017 15:50:00 -0500 https://ca.proactiveinvestors.com/companies/news/187695/dutch-healthcare-and-electronics-giant-philips-to-use-angles-parsortix-system-as-part-of-four-year-collaboration-187695.html ANGLE catches tumour cells 'hibernating' in bone marrow in new study https://ca.proactiveinvestors.com/companies/news/186008/angle-catches-tumour-cells-hibernating-in-bone-marrow-in-new-study-186008.html Mon, 23 Oct 2017 13:04:00 -0400 https://ca.proactiveinvestors.com/companies/news/186008/angle-catches-tumour-cells-hibernating-in-bone-marrow-in-new-study-186008.html ANGLE raises another £2.8mln https://ca.proactiveinvestors.com/companies/news/185475/angle-raises-another-28mln-185475.html Thu, 12 Oct 2017 06:22:00 -0400 https://ca.proactiveinvestors.com/companies/news/185475/angle-raises-another-28mln-185475.html ANGLE continues to make progress with Parsortix https://ca.proactiveinvestors.com/companies/news/185234/angle-continues-to-make-progress-with-parsortix-185234.html Mon, 09 Oct 2017 06:37:00 -0400 https://ca.proactiveinvestors.com/companies/news/185234/angle-continues-to-make-progress-with-parsortix-185234.html ANGLE to offer a full liquid biopsy 'sample to answer' solution following Axela acquisition https://ca.proactiveinvestors.com/companies/news/308199/angle-to-offer-a-full-liquid-biopsy-sample-to-answer-solution-following-axela-acquisition-8199.html Thu, 05 Oct 2017 18:31:00 -0400 https://ca.proactiveinvestors.com/companies/news/308199/angle-to-offer-a-full-liquid-biopsy-sample-to-answer-solution-following-axela-acquisition-8199.html ANGLE acquires complementary Canadian intellectual property https://ca.proactiveinvestors.com/companies/news/185105/angle-acquires-complementary-canadian-intellectual-property-185105.html Thu, 05 Oct 2017 07:19:00 -0400 https://ca.proactiveinvestors.com/companies/news/185105/angle-acquires-complementary-canadian-intellectual-property-185105.html ANGLE agreement could open up whole new area of cancer diagnostics https://ca.proactiveinvestors.com/companies/news/183883/angle-agreement-could-open-up-whole-new-area-of-cancer-diagnostics-183883.html Wed, 13 Sep 2017 09:29:00 -0400 https://ca.proactiveinvestors.com/companies/news/183883/angle-agreement-could-open-up-whole-new-area-of-cancer-diagnostics-183883.html ANGLE inks agreement with world-leading molecular testing provider https://ca.proactiveinvestors.com/companies/news/308062/angle-inks-agreement-with-world-leading-molecular-testing-provider-8062.html Mon, 11 Sep 2017 11:08:00 -0400 https://ca.proactiveinvestors.com/companies/news/308062/angle-inks-agreement-with-world-leading-molecular-testing-provider-8062.html ANGLE establishes co-marketing agreement with leading molecular testing solutions provider QIAGEN https://ca.proactiveinvestors.com/companies/news/183723/angle-establishes-co-marketing-agreement-with-leading-molecular-testing-solutions-provider-qiagen-183723.html Mon, 11 Sep 2017 08:00:00 -0400 https://ca.proactiveinvestors.com/companies/news/183723/angle-establishes-co-marketing-agreement-with-leading-molecular-testing-solutions-provider-qiagen-183723.html Broker targeting near-tripling in ANGLE's share price as Parsortix development strides forward https://ca.proactiveinvestors.com/companies/news/183459/broker-targeting-near-tripling-in-angle-s-share-price-as-parsortix-development-strides-forward-183459.html Tue, 05 Sep 2017 11:55:00 -0400 https://ca.proactiveinvestors.com/companies/news/183459/broker-targeting-near-tripling-in-angle-s-share-price-as-parsortix-development-strides-forward-183459.html ANGLE says research further demonstrates key advantages of Parsortix system for cancer treatment https://ca.proactiveinvestors.com/companies/news/183369/angle-says-research-further-demonstrates-key-advantages-of-parsortix-system-for-cancer-treatment-183369.html Mon, 04 Sep 2017 07:17:00 -0400 https://ca.proactiveinvestors.com/companies/news/183369/angle-says-research-further-demonstrates-key-advantages-of-parsortix-system-for-cancer-treatment-183369.html ANGLE building the evidence base for breakthrough cancer detection system https://ca.proactiveinvestors.com/companies/news/181544/angle-building-the-evidence-base-for-breakthrough-cancer-detection-system-181544.html Thu, 27 Jul 2017 14:45:00 -0400 https://ca.proactiveinvestors.com/companies/news/181544/angle-building-the-evidence-base-for-breakthrough-cancer-detection-system-181544.html ANGLE hails results from landmark ovarian cancer study which underlines potential of its liquid biopsy https://ca.proactiveinvestors.com/companies/news/180277/angle-hails-results-from-landmark-ovarian-cancer-study-which-underlines-potential-of-its-liquid-biopsy-180277.html Tue, 04 Jul 2017 11:29:00 -0400 https://ca.proactiveinvestors.com/companies/news/180277/angle-hails-results-from-landmark-ovarian-cancer-study-which-underlines-potential-of-its-liquid-biopsy-180277.html ANGLE PLC boss 'absolutely delighted' with results from pelvic mass study https://ca.proactiveinvestors.com/companies/news/307742/angle-plc-boss-absolutely-delighted-with-results-from-pelvic-mass-study-7742.html Tue, 04 Jul 2017 10:47:00 -0400 https://ca.proactiveinvestors.com/companies/news/307742/angle-plc-boss-absolutely-delighted-with-results-from-pelvic-mass-study-7742.html ANGLE liquid biopsy crucial to prostate cancer breakthrough https://ca.proactiveinvestors.com/companies/news/179282/angle-liquid-biopsy-crucial-to-prostate-cancer-breakthrough-179282.html Thu, 15 Jun 2017 14:26:00 -0400 https://ca.proactiveinvestors.com/companies/news/179282/angle-liquid-biopsy-crucial-to-prostate-cancer-breakthrough-179282.html ANGLE PLC's Andrew Newland on 'very exciting' liquid biopsy breakthrough https://ca.proactiveinvestors.com/companies/news/307644/angle-plc-s-andrew-newland-on-very-exciting-liquid-biopsy-breakthrough-7644.html Thu, 15 Jun 2017 11:52:00 -0400 https://ca.proactiveinvestors.com/companies/news/307644/angle-plc-s-andrew-newland-on-very-exciting-liquid-biopsy-breakthrough-7644.html ANGLE liquid biopsy yields predictive results in colorectal cancer https://ca.proactiveinvestors.com/companies/news/178753/angle-liquid-biopsy-yields-predictive-results-in-colorectal-cancer-178753.html Mon, 05 Jun 2017 06:34:00 -0400 https://ca.proactiveinvestors.com/companies/news/178753/angle-liquid-biopsy-yields-predictive-results-in-colorectal-cancer-178753.html ANGLE making "good progress" with studies well underway and commercial traction being felt https://ca.proactiveinvestors.com/companies/news/177219/angle-making-good-progress-with-studies-well-underway-and-commercial-traction-being-felt-177219.html Wed, 03 May 2017 13:09:00 -0400 https://ca.proactiveinvestors.com/companies/news/177219/angle-making-good-progress-with-studies-well-underway-and-commercial-traction-being-felt-177219.html 'Customer data validates strategy' for cancer diagnostic, says ANGLE PLC boss Andrew Newland https://ca.proactiveinvestors.com/companies/news/307228/-customer-data-validates-strategy-for-cancer-diagnostic-says-angle-plc-boss-andrew-newland-7228.html Tue, 04 Apr 2017 14:15:00 -0400 https://ca.proactiveinvestors.com/companies/news/307228/-customer-data-validates-strategy-for-cancer-diagnostic-says-angle-plc-boss-andrew-newland-7228.html ANGLE: Latest data burnishes credential of breakthrough cancer diagnostic https://ca.proactiveinvestors.com/companies/news/175817/angle-latest-data-burnishes-credential-of-breakthrough-cancer-diagnostic-175817.html Mon, 03 Apr 2017 07:04:00 -0400 https://ca.proactiveinvestors.com/companies/news/175817/angle-latest-data-burnishes-credential-of-breakthrough-cancer-diagnostic-175817.html ANGLE device offers breakthrough in detecting and predicting spread of prostate cancer https://ca.proactiveinvestors.com/companies/news/175667/angle-device-offers-breakthrough-in-detecting-and-predicting-spread-of-prostate-cancer-175667.html Thu, 30 Mar 2017 07:36:00 -0400 https://ca.proactiveinvestors.com/companies/news/175667/angle-device-offers-breakthrough-in-detecting-and-predicting-spread-of-prostate-cancer-175667.html ANGLE's blood screening tech developing into key ally for battle against cancer https://ca.proactiveinvestors.com/companies/news/173075/angle-s-blood-screening-tech-developing-into-key-ally-for-battle-against-cancer-173075.html Mon, 13 Feb 2017 14:39:00 -0500 https://ca.proactiveinvestors.com/companies/news/173075/angle-s-blood-screening-tech-developing-into-key-ally-for-battle-against-cancer-173075.html ANGLE part of consortium that will set set standard for identifying cancer https://ca.proactiveinvestors.com/companies/news/173042/angle-part-of-consortium-that-will-set-set-standard-for-identifying-cancer-173042.html Mon, 13 Feb 2017 07:21:00 -0500 https://ca.proactiveinvestors.com/companies/news/173042/angle-part-of-consortium-that-will-set-set-standard-for-identifying-cancer-173042.html ANGLE - early results from ovarian cancer study encourage; making signficant headway elsewhere https://ca.proactiveinvestors.com/companies/news/172209/angle-early-results-from-ovarian-cancer-study-encourage-making-signficant-headway-elsewhere-172209.html Thu, 26 Jan 2017 08:07:00 -0500 https://ca.proactiveinvestors.com/companies/news/172209/angle-early-results-from-ovarian-cancer-study-encourage-making-signficant-headway-elsewhere-172209.html ANGLE device offers breakthrough in prostate cancer care https://ca.proactiveinvestors.com/companies/news/168529/angle-device-offers-breakthrough-in-prostate-cancer-care-168529.html Fri, 04 Nov 2016 07:53:00 -0400 https://ca.proactiveinvestors.com/companies/news/168529/angle-device-offers-breakthrough-in-prostate-cancer-care-168529.html ANGLE's parsortix gets favourable peer review for use in therapy selection https://ca.proactiveinvestors.com/companies/news/166754/angle-s-parsortix-gets-favourable-peer-review-for-use-in-therapy-selection-166754.html Fri, 30 Sep 2016 08:00:00 -0400 https://ca.proactiveinvestors.com/companies/news/166754/angle-s-parsortix-gets-favourable-peer-review-for-use-in-therapy-selection-166754.html ANGLE’s Parsortix to be in focus at AACC annual meeting https://ca.proactiveinvestors.com/companies/news/128901/angles-parsortix-to-be-in-focus-at-aacc-annual-meeting-128901.html Tue, 02 Aug 2016 12:29:00 -0400 https://ca.proactiveinvestors.com/companies/news/128901/angles-parsortix-to-be-in-focus-at-aacc-annual-meeting-128901.html ANGLE's new blood screening tech to revolutionise cancer diagnosis https://ca.proactiveinvestors.com/companies/news/124967/angle-s-new-blood-screening-tech-to-revolutionise-cancer-diagnosis-124967.html Thu, 28 Jul 2016 11:00:00 -0400 https://ca.proactiveinvestors.com/companies/news/124967/angle-s-new-blood-screening-tech-to-revolutionise-cancer-diagnosis-124967.html Angle’s Newland reflects on excellent year as cancer patient trials advance https://ca.proactiveinvestors.com/companies/news/305333/angles-newland-reflects-on-excellent-year-as-cancer-patient-trials-advance-5333.html Thu, 28 Jul 2016 09:43:00 -0400 https://ca.proactiveinvestors.com/companies/news/305333/angles-newland-reflects-on-excellent-year-as-cancer-patient-trials-advance-5333.html ANGLE well funded and making good progress https://ca.proactiveinvestors.com/companies/news/128724/angle-well-funded-and-making-good-progress-128724.html Thu, 28 Jul 2016 06:35:00 -0400 https://ca.proactiveinvestors.com/companies/news/128724/angle-well-funded-and-making-good-progress-128724.html ANGLE starts US ovarian cancer study https://ca.proactiveinvestors.com/companies/news/128680/angle-starts-us-ovarian-cancer-study-128680.html Wed, 27 Jul 2016 07:05:00 -0400 https://ca.proactiveinvestors.com/companies/news/128680/angle-starts-us-ovarian-cancer-study-128680.html ANGLE kicks off ovarian cancer study for Parsortix https://ca.proactiveinvestors.com/companies/news/128328/angle-kicks-off-ovarian-cancer-study-for-parsortix-128328.html Tue, 19 Jul 2016 07:12:00 -0400 https://ca.proactiveinvestors.com/companies/news/128328/angle-kicks-off-ovarian-cancer-study-for-parsortix-128328.html Angle takes step forward with Parsortix https://ca.proactiveinvestors.com/companies/news/128231/angle-takes-step-forward-with-parsortix-128231.html Fri, 15 Jul 2016 07:05:00 -0400 https://ca.proactiveinvestors.com/companies/news/128231/angle-takes-step-forward-with-parsortix-128231.html ANGLE in £10mln fundraiser; inks Manchester Uni deal https://ca.proactiveinvestors.com/companies/news/126350/angle-in-10mln-fundraiser-inks-manchester-uni-deal-126350.html Wed, 25 May 2016 13:36:00 -0400 https://ca.proactiveinvestors.com/companies/news/126350/angle-in-10mln-fundraiser-inks-manchester-uni-deal-126350.html ANGLE chief sees Parsotix sales “turbocharged” by Manchester Uni deal https://ca.proactiveinvestors.com/companies/news/305073/angle-chief-sees-parsotix-sales-turbocharged-by-manchester-uni-deal-5073.html Wed, 25 May 2016 07:10:00 -0400 https://ca.proactiveinvestors.com/companies/news/305073/angle-chief-sees-parsotix-sales-turbocharged-by-manchester-uni-deal-5073.html ANGLE PLC underscores attention Parsortix is receiving https://ca.proactiveinvestors.com/companies/news/125400/angle-plc-underscores-attention-parsortix-is-receiving-125400.html Fri, 29 Apr 2016 07:02:00 -0400 https://ca.proactiveinvestors.com/companies/news/125400/angle-plc-underscores-attention-parsortix-is-receiving-125400.html ANGLE chief highlights latest positive Parsortix data from USC https://ca.proactiveinvestors.com/companies/news/304907/angle-chief-highlights-latest-positive-parsortix-data-from-usc-4907.html Mon, 18 Apr 2016 13:20:00 -0400 https://ca.proactiveinvestors.com/companies/news/304907/angle-chief-highlights-latest-positive-parsortix-data-from-usc-4907.html ANGLE device able to track spread of breast cancer https://ca.proactiveinvestors.com/companies/news/124880/angle-device-able-to-track-spread-of-breast-cancer-124880.html Mon, 18 Apr 2016 06:42:00 -0400 https://ca.proactiveinvestors.com/companies/news/124880/angle-device-able-to-track-spread-of-breast-cancer-124880.html ANGLE plc’s Parsortix a “game-changer” for prostate cancer detection, says CEO https://ca.proactiveinvestors.com/companies/news/304798/angle-plcs-parsortix-a-game-changer-for-prostate-cancer-detection-says-ceo-4798.html Mon, 21 Mar 2016 11:33:00 -0400 https://ca.proactiveinvestors.com/companies/news/304798/angle-plcs-parsortix-a-game-changer-for-prostate-cancer-detection-says-ceo-4798.html ANGLE PLC makes prostate cancer breakthrough https://ca.proactiveinvestors.com/companies/news/123889/angle-plc-makes-prostate-cancer-breakthrough-123889.html Mon, 21 Mar 2016 07:56:00 -0400 https://ca.proactiveinvestors.com/companies/news/123889/angle-plc-makes-prostate-cancer-breakthrough-123889.html Angle CEO Andrew Newland outlines the merits of the company's Parsortix System https://ca.proactiveinvestors.com/companies/news/304753/angle-ceo-andrew-newland-outlines-the-merits-of-the-company-s-parsortix-system-4753.html Wed, 09 Mar 2016 13:32:00 -0500 https://ca.proactiveinvestors.com/companies/news/304753/angle-ceo-andrew-newland-outlines-the-merits-of-the-company-s-parsortix-system-4753.html ANGLE PLC granted European patent for liquid biopsy https://ca.proactiveinvestors.com/companies/news/123456/angle-plc-granted-european-patent-for-liquid-biopsy-123456.html Wed, 09 Mar 2016 08:21:00 -0500 https://ca.proactiveinvestors.com/companies/news/123456/angle-plc-granted-european-patent-for-liquid-biopsy-123456.html Angle expects "deluge of news" in months ahead as Parsortix makes progress https://ca.proactiveinvestors.com/companies/news/304592/angle-expects-deluge-of-news-in-months-ahead-as-parsortix-makes-progress-4592.html Thu, 28 Jan 2016 15:54:00 -0500 https://ca.proactiveinvestors.com/companies/news/304592/angle-expects-deluge-of-news-in-months-ahead-as-parsortix-makes-progress-4592.html ANGLE's interims chart Parsortix's progress https://ca.proactiveinvestors.com/companies/news/121862/angle-s-interims-chart-parsortix-s-progress-121862.html Thu, 28 Jan 2016 08:16:00 -0500 https://ca.proactiveinvestors.com/companies/news/121862/angle-s-interims-chart-parsortix-s-progress-121862.html ANGLE technology backed by leading cancer centre https://ca.proactiveinvestors.com/companies/news/121683/angle-technology-backed-by-leading-cancer-centre-121683.html Mon, 25 Jan 2016 07:37:00 -0500 https://ca.proactiveinvestors.com/companies/news/121683/angle-technology-backed-by-leading-cancer-centre-121683.html Angle receives final payment for Geomerics sale https://ca.proactiveinvestors.com/companies/news/120729/angle-receives-final-payment-for-geomerics-sale-120729.html Tue, 22 Dec 2015 08:04:00 -0500 https://ca.proactiveinvestors.com/companies/news/120729/angle-receives-final-payment-for-geomerics-sale-120729.html ANGLE passes commercial milestone with first sale https://ca.proactiveinvestors.com/companies/news/120462/angle-passes-commercial-milestone-with-first-sale-120462.html Tue, 15 Dec 2015 12:58:00 -0500 https://ca.proactiveinvestors.com/companies/news/120462/angle-passes-commercial-milestone-with-first-sale-120462.html ANGLE CEO says first commercialisation is a “major step forward” https://ca.proactiveinvestors.com/companies/news/304491/angle-ceo-says-first-commercialisation-is-a-major-step-forward-4491.html Tue, 15 Dec 2015 12:49:00 -0500 https://ca.proactiveinvestors.com/companies/news/304491/angle-ceo-says-first-commercialisation-is-a-major-step-forward-4491.html ANGLE welcomes stock market reclassification https://ca.proactiveinvestors.com/companies/news/120284/angle-welcomes-stock-market-reclassification-120284.html Thu, 10 Dec 2015 08:20:00 -0500 https://ca.proactiveinvestors.com/companies/news/120284/angle-welcomes-stock-market-reclassification-120284.html ANGLE CEO Andrew Newland outlines the merits of the company's Parsortix System https://ca.proactiveinvestors.com/companies/news/304417/angle-ceo-andrew-newland-outlines-the-merits-of-the-company-s-parsortix-system-4417.html Fri, 27 Nov 2015 12:25:00 -0500 https://ca.proactiveinvestors.com/companies/news/304417/angle-ceo-andrew-newland-outlines-the-merits-of-the-company-s-parsortix-system-4417.html High quality evidence driving Parsortix commercial value, says ANGLE CEO https://ca.proactiveinvestors.com/companies/news/304375/high-quality-evidence-driving-parsortix-commercial-value-says-angle-ceo-4375.html Wed, 18 Nov 2015 07:45:00 -0500 https://ca.proactiveinvestors.com/companies/news/304375/high-quality-evidence-driving-parsortix-commercial-value-says-angle-ceo-4375.html ANGLE poised to make major impact in cancer patient care https://ca.proactiveinvestors.com/companies/news/119322/angle-poised-to-make-major-impact-in-cancer-patient-care-119322.html Tue, 17 Nov 2015 16:05:00 -0500 https://ca.proactiveinvestors.com/companies/news/119322/angle-poised-to-make-major-impact-in-cancer-patient-care-119322.html Angle's Parsortix device could become a clinical routine, reckon brokers https://ca.proactiveinvestors.com/companies/news/119320/angle-s-parsortix-device-could-become-a-clinical-routine-reckon-brokers-119320.html Tue, 17 Nov 2015 16:04:00 -0500 https://ca.proactiveinvestors.com/companies/news/119320/angle-s-parsortix-device-could-become-a-clinical-routine-reckon-brokers-119320.html ANGLE outperforms the 'gold standard' in lung cancer study https://ca.proactiveinvestors.com/companies/news/119267/angle-outperforms-the-gold-standard-in-lung-cancer-study-119267.html Tue, 17 Nov 2015 14:39:00 -0500 https://ca.proactiveinvestors.com/companies/news/119267/angle-outperforms-the-gold-standard-in-lung-cancer-study-119267.html ANGLE secures Canadian patent for cancer technology https://ca.proactiveinvestors.com/companies/news/116199/angle-secures-canadian-patent-for-cancer-technology-116199.html Wed, 14 Oct 2015 07:08:00 -0400 https://ca.proactiveinvestors.com/companies/news/116199/angle-secures-canadian-patent-for-cancer-technology-116199.html ANGLE researchers copper bottom ovarian cancer results https://ca.proactiveinvestors.com/companies/news/111171/angle-researchers-copper-bottom-ovarian-cancer-results-111171.html Mon, 28 Sep 2015 07:04:00 -0400 https://ca.proactiveinvestors.com/companies/news/111171/angle-researchers-copper-bottom-ovarian-cancer-results-111171.html ANGLE technology gets strong endorsement from cancer researchers at Bart's https://ca.proactiveinvestors.com/companies/news/111079/angle-technology-gets-strong-endorsement-from-cancer-researchers-at-bart-s-111079.html Thu, 24 Sep 2015 13:31:00 -0400 https://ca.proactiveinvestors.com/companies/news/111079/angle-technology-gets-strong-endorsement-from-cancer-researchers-at-bart-s-111079.html ANGLE CEO eyes research market sales following Barts endorsement https://ca.proactiveinvestors.com/companies/news/304177/angle-ceo-eyes-research-market-sales-following-barts-endorsement-4177.html Thu, 24 Sep 2015 13:10:00 -0400 https://ca.proactiveinvestors.com/companies/news/304177/angle-ceo-eyes-research-market-sales-following-barts-endorsement-4177.html ANGLE 'encouraged' by results from breast cancer study https://ca.proactiveinvestors.com/companies/news/110632/angle-encouraged-by-results-from-breast-cancer-study-110632.html Wed, 09 Sep 2015 06:29:00 -0400 https://ca.proactiveinvestors.com/companies/news/110632/angle-encouraged-by-results-from-breast-cancer-study-110632.html UPDATE - ANGLE ups R&D investment https://ca.proactiveinvestors.com/companies/news/109266/update-angle-ups-rd-investment-109266.html Thu, 23 Jul 2015 15:52:00 -0400 https://ca.proactiveinvestors.com/companies/news/109266/update-angle-ups-rd-investment-109266.html ANGLE chief hails year of significant progress https://ca.proactiveinvestors.com/companies/news/303981/angle-chief-hails-year-of-significant-progress-3981.html Thu, 23 Jul 2015 10:24:00 -0400 https://ca.proactiveinvestors.com/companies/news/303981/angle-chief-hails-year-of-significant-progress-3981.html UPDATE - ANGLE beefs up its scientific advisory board https://ca.proactiveinvestors.com/companies/news/108789/update-angle-beefs-up-its-scientific-advisory-board-108789.html Wed, 08 Jul 2015 15:57:00 -0400 https://ca.proactiveinvestors.com/companies/news/108789/update-angle-beefs-up-its-scientific-advisory-board-108789.html Angle (LON:AGL) - Investor Presentation - 2nd July https://ca.proactiveinvestors.com/companies/news/303974/angle-lonagl-investor-presentation-2nd-july-3974.html Thu, 02 Jul 2015 15:00:00 -0400 https://ca.proactiveinvestors.com/companies/news/303974/angle-lonagl-investor-presentation-2nd-july-3974.html Next Thursday's event brings together four London listed companies with huge potential. https://ca.proactiveinvestors.com/companies/news/108405/next-thursday-s-event-brings-together-four-london-listed-companies-with-huge-potential-108405.html Fri, 26 Jun 2015 16:30:00 -0400 https://ca.proactiveinvestors.com/companies/news/108405/next-thursday-s-event-brings-together-four-london-listed-companies-with-huge-potential-108405.html UPDATE - ANGLE: Barts prostate study yields 'encouraging' results https://ca.proactiveinvestors.com/companies/news/107922/update-angle-barts-prostate-study-yields-encouraging-results-107922.html Thu, 11 Jun 2015 15:25:00 -0400 https://ca.proactiveinvestors.com/companies/news/107922/update-angle-barts-prostate-study-yields-encouraging-results-107922.html ANGLE CEO on important new prostate cancer results https://ca.proactiveinvestors.com/companies/news/303854/angle-ceo-on-important-new-prostate-cancer-results-3854.html Thu, 11 Jun 2015 14:34:00 -0400 https://ca.proactiveinvestors.com/companies/news/303854/angle-ceo-on-important-new-prostate-cancer-results-3854.html ANGLE hires CTC specialist as new scientific advisor https://ca.proactiveinvestors.com/companies/news/107644/angle-hires-ctc-specialist-as-new-scientific-advisor-107644.html Wed, 03 Jun 2015 06:42:00 -0400 https://ca.proactiveinvestors.com/companies/news/107644/angle-hires-ctc-specialist-as-new-scientific-advisor-107644.html ANGLE gains Parsortix patent protection in China and Australia https://ca.proactiveinvestors.com/companies/news/107331/angle-gains-parsortix-patent-protection-in-china-and-australia-107331.html Tue, 26 May 2015 07:22:00 -0400 https://ca.proactiveinvestors.com/companies/news/107331/angle-gains-parsortix-patent-protection-in-china-and-australia-107331.html ROUNDUP – ANGLE up 12% after studies point to simple blood test for ovarian and breast cancer https://ca.proactiveinvestors.com/companies/news/68252/roundup-angle-up-12-after-studies-point-to-simple-blood-test-for-ovarian-and-breast-cancer-79521.html Two key announcements in two days appear to have done the trick for med-tech firm ANGLE (LON:AGL), whose shares are up 12%.

]]>
Tue, 21 Apr 2015 13:30:00 -0400 https://ca.proactiveinvestors.com/companies/news/68252/roundup-angle-up-12-after-studies-point-to-simple-blood-test-for-ovarian-and-breast-cancer-79521.html
ANGLE boss on breakthrough ovarian cancer results https://ca.proactiveinvestors.com/companies/news/303235/angle-boss-on-breakthrough-ovarian-cancer-results-3691.html Tue, 21 Apr 2015 11:48:00 -0400 https://ca.proactiveinvestors.com/companies/news/303235/angle-boss-on-breakthrough-ovarian-cancer-results-3691.html ANGLE partner reveals the potential of combined approach to spotting cancer https://ca.proactiveinvestors.com/companies/news/68220/angle-partner-reveals-the-potential-of-combined-approach-to-spotting-cancer-79484.html Med-tech firm ANGLE said its collaboration partner has published ‘highly encouraging’ results from using the firm’s Parsortix system for harvesting circulating tumour cells in harness with genetic markers.

]]>
Tue, 21 Apr 2015 06:31:00 -0400 https://ca.proactiveinvestors.com/companies/news/68220/angle-partner-reveals-the-potential-of-combined-approach-to-spotting-cancer-79484.html
ANGLE study results to be poster at major US cancer event https://ca.proactiveinvestors.com/companies/news/68184/angle-study-results-to-be-poster-at-major-us-cancer-event-79443.html Mon, 20 Apr 2015 07:58:00 -0400 https://ca.proactiveinvestors.com/companies/news/68184/angle-study-results-to-be-poster-at-major-us-cancer-event-79443.html ANGLE shareholders clamour for shares https://ca.proactiveinvestors.com/companies/news/66782/angle-shareholders-clamour-for-shares-77917.html Wed, 04 Mar 2015 10:25:00 -0500 https://ca.proactiveinvestors.com/companies/news/66782/angle-shareholders-clamour-for-shares-77917.html ANGLE rises sharply after Henderson lifts stake above 5% https://ca.proactiveinvestors.com/companies/news/66426/angle-rises-sharply-after-henderson-lifts-stake-above-5-77523.html Fri, 20 Feb 2015 15:32:00 -0500 https://ca.proactiveinvestors.com/companies/news/66426/angle-rises-sharply-after-henderson-lifts-stake-above-5-77523.html ANGLE to step up ovarian cancer pace with fund raise https://ca.proactiveinvestors.com/companies/news/66229/angle-to-step-up-ovarian-cancer-pace-with-fund-raise-77307.html ANGLE will raise £7.3mln through a placing at 65p per share and up to a further £1.5mln through an offer to existing shareholders.

]]>
Mon, 16 Feb 2015 13:46:00 -0500 https://ca.proactiveinvestors.com/companies/news/66229/angle-to-step-up-ovarian-cancer-pace-with-fund-raise-77307.html
ANGLE CEO: Fully funded for Parsortix ovarian cancer care, new partnership with MD Anderson https://ca.proactiveinvestors.com/companies/news/303032/angle-ceo-fully-funded-for-parsortix-ovarian-cancer-care-new-partnership-with-md-anderson--3478.html Mon, 16 Feb 2015 10:40:00 -0500 https://ca.proactiveinvestors.com/companies/news/303032/angle-ceo-fully-funded-for-parsortix-ovarian-cancer-care-new-partnership-with-md-anderson--3478.html ANGLE CEO hoping to gain FDA approval ‘later this year’ https://ca.proactiveinvestors.com/companies/news/303007/angle-ceo-hoping-to-gain-fda-approval-later-this-year-3443.html Thu, 29 Jan 2015 16:34:00 -0500 https://ca.proactiveinvestors.com/companies/news/303007/angle-ceo-hoping-to-gain-fda-approval-later-this-year-3443.html ANGLE says it is 'engaged constructively' with US regulators as updates on progress https://ca.proactiveinvestors.com/companies/news/65719/angle-says-it-is-engaged-constructively-with-us-regulators-as-updates-on-progress-76728.html Thu, 29 Jan 2015 06:59:00 -0500 https://ca.proactiveinvestors.com/companies/news/65719/angle-says-it-is-engaged-constructively-with-us-regulators-as-updates-on-progress-76728.html ANGLE breakthrough hailed for 'unprecedented' performance in detecting ovarian cancer https://ca.proactiveinvestors.com/companies/news/65622/angle-breakthrough-hailed-for-unprecedented-performance-in-detecting-ovarian-cancer--76623.html A clinical study of medtech firm ANGLE’s Parsortix system for harvesting circulating tumour cells has hailed its “unprecedented sensitivity and specificity” in identifying ovarian cancer.

]]>
Tue, 27 Jan 2015 15:46:00 -0500 https://ca.proactiveinvestors.com/companies/news/65622/angle-breakthrough-hailed-for-unprecedented-performance-in-detecting-ovarian-cancer--76623.html
ANGLE and EKF Diagnostics to collaborate on cancer test https://ca.proactiveinvestors.com/companies/news/65557/angle-and-ekf-diagnostics-to-collaborate-on-cancer-test-76542.html The two AIM-listed biotechs will initially target colorectal cancer but the ambition is to test for all forms of cancer in one combined solution if successful.

]]>
Fri, 23 Jan 2015 06:48:00 -0500 https://ca.proactiveinvestors.com/companies/news/65557/angle-and-ekf-diagnostics-to-collaborate-on-cancer-test-76542.html
Angle CEO explains benefits of teaming up with multinational https://ca.proactiveinvestors.com/companies/news/302946/angle-ceo-explains-benefits-of-teaming-up-with-multinational-3382.html Thu, 08 Jan 2015 14:36:00 -0500 https://ca.proactiveinvestors.com/companies/news/302946/angle-ceo-explains-benefits-of-teaming-up-with-multinational-3382.html ANGLE inks Parsortix collaboration agreement with multinational https://ca.proactiveinvestors.com/companies/news/65098/angle-inks-parsortix-collaboration-agreement-with-multinational-76020.html Thu, 08 Jan 2015 06:44:00 -0500 https://ca.proactiveinvestors.com/companies/news/65098/angle-inks-parsortix-collaboration-agreement-with-multinational-76020.html ANGLE cancer detection system shows "great promise", says leading researcher https://ca.proactiveinvestors.com/companies/news/64546/angle-cancer-detection-system-shows-great-promise-says-leading-researcher-75391.html Mon, 15 Dec 2014 06:49:00 -0500 https://ca.proactiveinvestors.com/companies/news/64546/angle-cancer-detection-system-shows-great-promise-says-leading-researcher-75391.html ANGLE's ADRs start trading today https://ca.proactiveinvestors.com/companies/news/63201/angles-adrs-start-trading-today-73847.html Fri, 31 Oct 2014 06:38:00 -0400 https://ca.proactiveinvestors.com/companies/news/63201/angles-adrs-start-trading-today-73847.html ANGLE's Parsortix receives strong endorsement from four leading cancer researchers https://ca.proactiveinvestors.com/companies/news/62790/angles-parsortix-receives-strong-endorsement-from-four-leading-cancer-researchers--73362.html Fri, 17 Oct 2014 06:43:00 -0400 https://ca.proactiveinvestors.com/companies/news/62790/angles-parsortix-receives-strong-endorsement-from-four-leading-cancer-researchers--73362.html ANGLE plc announces second breast cancer collaboration https://ca.proactiveinvestors.com/companies/news/62229/angle-plc-announces-second-breast-cancer-collaboration-72743.html Tue, 30 Sep 2014 07:16:00 -0400 https://ca.proactiveinvestors.com/companies/news/62229/angle-plc-announces-second-breast-cancer-collaboration-72743.html UPDATE - Angle opens up to US investment with launch of ADR programme https://ca.proactiveinvestors.com/companies/news/62085/update-angle-opens-up-to-us-investment-with-launch-of-adr-programme-72597.html Thu, 25 Sep 2014 14:41:00 -0400 https://ca.proactiveinvestors.com/companies/news/62085/update-angle-opens-up-to-us-investment-with-launch-of-adr-programme-72597.html ANGLE to collaborate with leading US breast cancer centre https://ca.proactiveinvestors.com/companies/news/61909/angle-to-collaborate-with-leading-us-breast-cancer-centre-72412.html Fri, 19 Sep 2014 06:46:00 -0400 https://ca.proactiveinvestors.com/companies/news/61909/angle-to-collaborate-with-leading-us-breast-cancer-centre-72412.html ANGLE in collaboration with Vienna team on ovarian cancer https://ca.proactiveinvestors.com/companies/news/61819/angle-in-collaboration-with-vienna-team-on-ovarian-cancer--72313.html Wed, 17 Sep 2014 07:17:00 -0400 https://ca.proactiveinvestors.com/companies/news/61819/angle-in-collaboration-with-vienna-team-on-ovarian-cancer--72313.html UPDATE - ANGLE inks collaboration with world leader to advance Parsortix https://ca.proactiveinvestors.com/companies/news/61494/update-angle-inks-collaboration-with-world-leader-to-advance-parsortix-71970.html Mon, 08 Sep 2014 12:40:00 -0400 https://ca.proactiveinvestors.com/companies/news/61494/update-angle-inks-collaboration-with-world-leader-to-advance-parsortix-71970.html ANGLE Plc - Investor Presentation - 3rd September 2014 https://ca.proactiveinvestors.com/companies/news/302657/ Thu, 04 Sep 2014 08:40:00 -0400 https://ca.proactiveinvestors.com/companies/news/302657/ ANGLE boosted as group strengthens patent hold on Parsortix https://ca.proactiveinvestors.com/companies/news/60556/angle-boosted-as-group-strengthens-patent-hold-on-parsortix-70967.html Shares in ANGLE nudged up at the start of the week as the group strengthened the protection over its blood cell separation technology - unveiling a second US patent.


]]>
Mon, 04 Aug 2014 11:05:00 -0400 https://ca.proactiveinvestors.com/companies/news/60556/angle-boosted-as-group-strengthens-patent-hold-on-parsortix-70967.html
ANGLE strengthens hold on Parsortix technology with second US patent https://ca.proactiveinvestors.com/companies/news/60544/angle-strengthens-hold-on-parsortix-technology-with-second-us-patent-70955.html Mon, 04 Aug 2014 06:29:00 -0400 https://ca.proactiveinvestors.com/companies/news/60544/angle-strengthens-hold-on-parsortix-technology-with-second-us-patent-70955.html UPDATE - ANGLE's prelims chart significant progress with Parsortix system https://ca.proactiveinvestors.com/companies/news/60209/update-angles-prelims-chart-significant-progress-with-parsortix-system-70606.html Wed, 23 Jul 2014 13:46:00 -0400 https://ca.proactiveinvestors.com/companies/news/60209/update-angles-prelims-chart-significant-progress-with-parsortix-system-70606.html UPDATE - ANGLE plc's Parsortix system receives positive evaluation https://ca.proactiveinvestors.com/companies/news/60176/update-angle-plcs-parsortix-system-receives-positive-evaluation-70573.html "Their extensive work provides us with a platform to secure clinical studies with key opinion leaders, which is the key next step towards widespread adoption of the Parsortix system in the treatment of cancer," said ANGLE CEO Andrew Newland, after the prestigious cancer research group evaluated the diagnostic system.

]]>
Tue, 22 Jul 2014 15:50:00 -0400 https://ca.proactiveinvestors.com/companies/news/60176/update-angle-plcs-parsortix-system-receives-positive-evaluation-70573.html
ANGLE strengthens intellectual property claims for Parsortix device https://ca.proactiveinvestors.com/companies/news/57213/angle-strengthens-intellectual-property-claims-for-parsortix-device-67440.html Tue, 08 Apr 2014 06:30:00 -0400 https://ca.proactiveinvestors.com/companies/news/57213/angle-strengthens-intellectual-property-claims-for-parsortix-device-67440.html ANGLE appoints scientific adviser https://ca.proactiveinvestors.com/companies/news/56736/angle-appoints-scientific-adviser-66935.html Mon, 24 Mar 2014 07:03:00 -0400 https://ca.proactiveinvestors.com/companies/news/56736/angle-appoints-scientific-adviser-66935.html UPDATE - ANGLE applies for US clearance for its breakthrough cancer detection device https://ca.proactiveinvestors.com/companies/news/56541/update-angle-applies-for-us-clearance-for-its-breakthrough-cancer-detection-device-66728.html Medical technology specialist ANGLE passed another significant milestone as it made its submission to America’s all powerful Food & Drug Administration for authorisation of its Parsortix cell separation system

]]>
Mon, 17 Mar 2014 11:35:00 -0400 https://ca.proactiveinvestors.com/companies/news/56541/update-angle-applies-for-us-clearance-for-its-breakthrough-cancer-detection-device-66728.html
Angle: Initial Parsortix study results revealed https://ca.proactiveinvestors.com/companies/news/55932/angle-initial-parsortix-study-results-revealed-66075.html Mon, 24 Feb 2014 07:17:00 -0500 https://ca.proactiveinvestors.com/companies/news/55932/angle-initial-parsortix-study-results-revealed-66075.html BIG PICTURE - Milestones coming thick and fast at ANGLE as it prepares to launch cancer diagnostic system https://ca.proactiveinvestors.com/companies/news/55773/big-picture-milestones-coming-thick-and-fast-at-angle-as-it-prepares-to-launch-cancer-diagnostic-system-65903.html The milestones are coming thick and fast for ANGLE, the med-tech group that has come up with a potential breakthrough in cancer diagnosis.

]]>
Tue, 18 Feb 2014 13:00:00 -0500 https://ca.proactiveinvestors.com/companies/news/55773/big-picture-milestones-coming-thick-and-fast-at-angle-as-it-prepares-to-launch-cancer-diagnostic-system-65903.html
ANGLE's revolutionary cancer diagnostic system to launch this week https://ca.proactiveinvestors.com/companies/news/55755/angles-revolutionary-cancer-diagnostic-system-to-launch-this-week-65885.html The eagerly anticipated launch of ANGLE’s ground-breaking cancer diagnostic system will take place at a conference in Berlin later this week, the company confirmed Tuesday.

]]>
Tue, 18 Feb 2014 06:41:00 -0500 https://ca.proactiveinvestors.com/companies/news/55755/angles-revolutionary-cancer-diagnostic-system-to-launch-this-week-65885.html
Angle focused on achieving widespread market adoption of Parsortix https://ca.proactiveinvestors.com/companies/news/55251/angle-focused-on-achieving-widespread-market-adoption-of-parsortix-65346.html Thu, 30 Jan 2014 07:07:00 -0500 https://ca.proactiveinvestors.com/companies/news/55251/angle-focused-on-achieving-widespread-market-adoption-of-parsortix-65346.html Angle plc aims to signs more deals https://ca.proactiveinvestors.com/companies/news/302199/angle-plc-aims-to-signs-more-deals--2499.html Wed, 29 Jan 2014 11:53:00 -0500 https://ca.proactiveinvestors.com/companies/news/302199/angle-plc-aims-to-signs-more-deals--2499.html ANGLE sets up Parsortix research laboratory at Cambridge https://ca.proactiveinvestors.com/companies/news/54734/angle-sets-up-parsortix-research-laboratory-at-cambridge--64781.html Mon, 13 Jan 2014 06:41:00 -0500 https://ca.proactiveinvestors.com/companies/news/54734/angle-sets-up-parsortix-research-laboratory-at-cambridge--64781.html ANGLE's team boosted by next-generation sequencing expert https://ca.proactiveinvestors.com/companies/news/54549/angles-team-boosted-by-next-generation-sequencing-expert-64591.html Tue, 07 Jan 2014 06:27:00 -0500 https://ca.proactiveinvestors.com/companies/news/54549/angles-team-boosted-by-next-generation-sequencing-expert-64591.html ANGLE plc makes key milestone with CE Mark https://ca.proactiveinvestors.com/companies/news/302136/angle-plc-makes-key-milestone-with-ce-mark--2428.html Tue, 17 Dec 2013 13:32:00 -0500 https://ca.proactiveinvestors.com/companies/news/302136/angle-plc-makes-key-milestone-with-ce-mark--2428.html UPDATE - ANGLE passes key milestone in Europe https://ca.proactiveinvestors.com/companies/news/54206/update-angle-passes-key-milestone-in-europe-64234.html The team at ANGLE can put their feet up and enjoy Christmas having hit their target of the award of the CE mark in the European Union for Parsotix. They won't be able to relax for long, however, as they are targeting a milestone in the US in the first quarter of 2014.

]]>
Tue, 17 Dec 2013 10:34:00 -0500 https://ca.proactiveinvestors.com/companies/news/54206/update-angle-passes-key-milestone-in-europe-64234.html
UPDATE - ARM Holdings snaps up ANGLE's computer games graphics business https://ca.proactiveinvestors.com/companies/news/54136/update-arm-holdings-snaps-up-angles-computer-games-graphics-business-64160.html ANGLE plc has sold its computer games graphics business Geomerics for £6.2mln to iPad chip designer ARM Holdings

]]>
Fri, 13 Dec 2013 09:10:00 -0500 https://ca.proactiveinvestors.com/companies/news/54136/update-arm-holdings-snaps-up-angles-computer-games-graphics-business-64160.html
Update: ANGLE pushing for EU regulatory approval by end of year https://ca.proactiveinvestors.com/companies/news/50053/update-angle-pushing-for-eu-regulatory-approval-by-end-of-year-59597.html ANGLE is keen to get its Parsortix medical device cleared for sale into the lucrative cancer diagnostic and treatment markets. The company is pushing for European approval by Christmas, while mid-2014 has been pencilled in for the US green light.

]]>
Wed, 31 Jul 2013 13:45:00 -0400 https://ca.proactiveinvestors.com/companies/news/50053/update-angle-pushing-for-eu-regulatory-approval-by-end-of-year-59597.html
ANGLE focused on commercial development of Parsortix https://ca.proactiveinvestors.com/companies/news/50034/angle-focused-on-commercial-development-of-parsortix-59568.html Wed, 31 Jul 2013 08:14:00 -0400 https://ca.proactiveinvestors.com/companies/news/50034/angle-focused-on-commercial-development-of-parsortix-59568.html UPDATE: ANGLE's Parsortix device gets a thumbs up from Paterson Institute https://ca.proactiveinvestors.com/companies/news/49854/update-angles-parsortix-device-gets-a-thumbs-up-from-paterson-institute-59364.html ANGLE's cancer diagnostic device Parsortix got a further boost after it received a positive evaluation from Cancer Research UK's Paterson Institute.

]]>
Thu, 25 Jul 2013 12:27:00 -0400 https://ca.proactiveinvestors.com/companies/news/49854/update-angles-parsortix-device-gets-a-thumbs-up-from-paterson-institute-59364.html
ANGLE technology receives strong third party validation in Surrey University study https://ca.proactiveinvestors.com/companies/news/49330/angle-technology-receives-strong-third-party-validation-in-surrey-university-study-58753.html The med-tech group ANGLE has received independent validation of its breakthrough Parsortix technology. Researchers at the University of Surrey successfully used the system to screen for colorectal cancer.

]]>
Mon, 08 Jul 2013 06:50:00 -0400 https://ca.proactiveinvestors.com/companies/news/49330/angle-technology-receives-strong-third-party-validation-in-surrey-university-study-58753.html
ANGLE appoints manufacturer for Parsortix machines https://ca.proactiveinvestors.com/companies/news/48120/angle-appoints-manufacturer-for-parsortix-machines-57355.html Tue, 28 May 2013 06:54:00 -0400 https://ca.proactiveinvestors.com/companies/news/48120/angle-appoints-manufacturer-for-parsortix-machines-57355.html UPDATE: ANGLE successfully automates Parsortix harvesting function https://ca.proactiveinvestors.com/companies/news/47661/update-angle-successfully-automates-parsortix-harvesting-function-56808.html Mon, 13 May 2013 14:21:00 -0400 https://ca.proactiveinvestors.com/companies/news/47661/update-angle-successfully-automates-parsortix-harvesting-function-56808.html ANGLE appoints regulatory expert as Parsortix development steps up a gear https://ca.proactiveinvestors.com/companies/news/47460/angle-appoints-regulatory-expert-as-parsortix-development-steps-up-a-gear-56589.html Expectation is for regulatory authorisation in the EU by the end of 2013 and a submission to the FDA in the US in early 2014.

]]>
Tue, 07 May 2013 14:46:00 -0400 https://ca.proactiveinvestors.com/companies/news/47460/angle-appoints-regulatory-expert-as-parsortix-development-steps-up-a-gear-56589.html
ANGLE launches cancer screening device into research market https://ca.proactiveinvestors.com/companies/news/45452/angle-launches-cancer-screening-device-into-research-market-54226.html The med-tech firm ANGLE plc has achieved a significant milestone in its development with the launch of its revolutionary cancer screening device into the research market.

]]>
Thu, 28 Feb 2013 11:30:00 -0500 https://ca.proactiveinvestors.com/companies/news/45452/angle-launches-cancer-screening-device-into-research-market-54226.html
ANGLE One2One Investor Presentation 13th February 2013 https://ca.proactiveinvestors.com/companies/news/301584/angle-one2one-investor-presentation-13th-february-2013-1722.html Thu, 14 Feb 2013 07:36:00 -0500 https://ca.proactiveinvestors.com/companies/news/301584/angle-one2one-investor-presentation-13th-february-2013-1722.html Proactiveinvestors One2One Forum this Wednesday: Probability, Angle, AFC Energy and Xenetic Bio https://ca.proactiveinvestors.com/companies/news/44827/proactiveinvestors-one2one-forum-this-wednesday-probability-angle-afc-energy-and-xenetic-bio-53481.html Probability, ANGLE, AFC Energy and Xenetic Biosciences each has a market leading technology with the potential to transform its particular field.


]]>
Fri, 08 Feb 2013 15:50:00 -0500 https://ca.proactiveinvestors.com/companies/news/44827/proactiveinvestors-one2one-forum-this-wednesday-probability-angle-afc-energy-and-xenetic-bio-53481.html
UPDATE: ANGLE unveils £2.2mln funding to advance Parsortix device https://ca.proactiveinvestors.com/companies/news/44544/update-angle-unveils-22mln-funding-to-advance-parsortix-device-53133.html ANGLE has raised £2.2 million to support the launch of its rapidly developing Parsortix device to the research market. Further down the road it has its eyes on the potentially huge clinical market.

]]>
Thu, 31 Jan 2013 15:28:00 -0500 https://ca.proactiveinvestors.com/companies/news/44544/update-angle-unveils-22mln-funding-to-advance-parsortix-device-53133.html
ANGLE unveils £2.2mln funding to advance Parsortix device https://ca.proactiveinvestors.com/companies/news/44512/angle-unveils-22mln-funding-to-advance-parsortix-device-53101.html Thu, 31 Jan 2013 06:30:00 -0500 https://ca.proactiveinvestors.com/companies/news/44512/angle-unveils-22mln-funding-to-advance-parsortix-device-53101.html ANGLE plc has "major breakthrough" for Parsortix https://ca.proactiveinvestors.com/companies/news/44394/angle-plc-has-major-breakthrough-for-parsortix-52963.html Andrew Newland, CEO of ANGLE plc (LON:AGL), tells Proactiveinvestors that the company has achieved a "major breakthrough" in the potential use of its Parsortix non-invasive cancer diagnostic product. Andrew discusses what it means for the company and what investors should now watch out for.

]]>
Mon, 28 Jan 2013 14:59:00 -0500 https://ca.proactiveinvestors.com/companies/news/44394/angle-plc-has-major-breakthrough-for-parsortix-52963.html
Perfect storm of patent expiries and M&A will see biotech stocks outperform, says broker https://ca.proactiveinvestors.com/companies/news/43970/perfect-storm-of-patent-expiries-and-ma-will-see-biotech-stocks-outperform-says-broker-52448.html The biotechnology and healthcare sector has entered a “sustained period of momentum underpinned by a perfect storm" of events, according to City broker Cenkos.

]]>
Tue, 15 Jan 2013 13:02:00 -0500 https://ca.proactiveinvestors.com/companies/news/43970/perfect-storm-of-patent-expiries-and-ma-will-see-biotech-stocks-outperform-says-broker-52448.html
ANGLE plc has "major breakthrough" for Parsortix https://ca.proactiveinvestors.com/companies/news/301528/angle-plc-has-major-breakthrough-for-parsortix-1630.html Tue, 15 Jan 2013 10:20:00 -0500 https://ca.proactiveinvestors.com/companies/news/301528/angle-plc-has-major-breakthrough-for-parsortix-1630.html ANGLE gets £178,000 settlement payment https://ca.proactiveinvestors.com/companies/news/43944/angle-gets-178000-settlement-payment-52419.html Tue, 15 Jan 2013 06:46:00 -0500 https://ca.proactiveinvestors.com/companies/news/43944/angle-gets-178000-settlement-payment-52419.html ANGLE's Parsortix breakthough is 'major step forward', says chief executive https://ca.proactiveinvestors.com/companies/news/43921/angles-parsortix-breakthough-is-major-step-forward-says-chief-executive-52373.html Today's news from ANGLE is a "major step forward" chief executive and founder of the firm Andrew Newland told Proactive. Shares soared 100% after the medical technology group announced a “major breakthrough” in finding a new use for its Parsortix cancer diagnostic device.

]]>
Mon, 14 Jan 2013 14:10:00 -0500 https://ca.proactiveinvestors.com/companies/news/43921/angles-parsortix-breakthough-is-major-step-forward-says-chief-executive-52373.html
ANGLE enlists new director https://ca.proactiveinvestors.com/companies/news/43660/angle-enlists-new-director-52070.html Mon, 07 Jan 2013 06:25:00 -0500 https://ca.proactiveinvestors.com/companies/news/43660/angle-enlists-new-director-52070.html ANGLE releases Parsortix to partners as co readies for first sales of cancer screening device https://ca.proactiveinvestors.com/companies/news/43286/angle-releases-parsortix-to-partners-as-co-readies-for-first-sales-of-cancer-screening-device-51646.html ANGLE this morning passed a significant milestone with the release of its cancer diagnostic product, Parsortix, to two research partners. The group also confirmed it is still on track to start limited sales of the potentially breakthrough device early in the New Year.

]]>
Tue, 18 Dec 2012 06:29:00 -0500 https://ca.proactiveinvestors.com/companies/news/43286/angle-releases-parsortix-to-partners-as-co-readies-for-first-sales-of-cancer-screening-device-51646.html
ANGLE says revolutionary cancer screening device will go on sale early in New Year https://ca.proactiveinvestors.com/companies/news/43024/angle-says-revolutionary-cancer-screening-device-will-go-on-sale-early-in-new-year-51347.html The med-tech company ANGLE said it expects to be able to release a research version of its potentially breakthrough Parsortix cancer screening device for sale to the research sector early in the New Year. This follows the successful development of the MK1 machine and the GEN3 cassette used to circulating tumour cells.

]]>
Mon, 10 Dec 2012 06:33:00 -0500 https://ca.proactiveinvestors.com/companies/news/43024/angle-says-revolutionary-cancer-screening-device-will-go-on-sale-early-in-new-year-51347.html
ANGLE appoints top medics to advise on Parsortix development https://ca.proactiveinvestors.com/companies/news/41344/angle-appoints-top-medics-to-advise-on-parsortix-development-49299.html Thu, 18 Oct 2012 07:45:00 -0400 https://ca.proactiveinvestors.com/companies/news/41344/angle-appoints-top-medics-to-advise-on-parsortix-development-49299.html Angle increases fundraising to £1.1mln as continues to progress Parsortix https://ca.proactiveinvestors.com/companies/news/39862/angle-increases-fundraising-to-11mln-as-continues-to-progress-parsortix-47581.html Mon, 03 Sep 2012 07:02:00 -0400 https://ca.proactiveinvestors.com/companies/news/39862/angle-increases-fundraising-to-11mln-as-continues-to-progress-parsortix-47581.html ANGLE's Parsortix attracts more investors and extra funding https://ca.proactiveinvestors.com/companies/news/38712/angles-parsortix-attracts-more-investors-and-extra-funding-46271.html Wed, 01 Aug 2012 07:06:00 -0400 https://ca.proactiveinvestors.com/companies/news/38712/angles-parsortix-attracts-more-investors-and-extra-funding-46271.html ANGLE has met all milestones set for Parsortix, says boss https://ca.proactiveinvestors.com/companies/news/38515/angle-has-met-all-milestones-set-for-parsortix-says-boss-46054.html The boss of intellectual property group ANGLE said today "all the milestones" set for its new cancer screening product Parsortix had been met.

]]>
Thu, 26 Jul 2012 12:17:00 -0400 https://ca.proactiveinvestors.com/companies/news/38515/angle-has-met-all-milestones-set-for-parsortix-says-boss-46054.html
ANGLE says development of Parsortix research product well underway https://ca.proactiveinvestors.com/companies/news/38500/angle-says-development-of-parsortix-research-product-well-underway-46038.html Thu, 26 Jul 2012 08:02:00 -0400 https://ca.proactiveinvestors.com/companies/news/38500/angle-says-development-of-parsortix-research-product-well-underway-46038.html ANGLE notes offer for Danish partner now unconditional https://ca.proactiveinvestors.com/companies/news/37385/angle-notes-offer-for-danish-partner-now-unconditional-44694.html Wed, 27 Jun 2012 07:10:00 -0400 https://ca.proactiveinvestors.com/companies/news/37385/angle-notes-offer-for-danish-partner-now-unconditional-44694.html ANGLE says looks forward to continuing relationship with bid target ORIGIO https://ca.proactiveinvestors.com/companies/news/36649/angle-says-looks-forward-to-continuing-relationship-with-bid-target-origio-43825.html Thu, 07 Jun 2012 07:05:00 -0400 https://ca.proactiveinvestors.com/companies/news/36649/angle-says-looks-forward-to-continuing-relationship-with-bid-target-origio-43825.html ANGLE's computer game associate earns final milestone https://ca.proactiveinvestors.com/companies/news/35868/angles-computer-game-associate-earns-final-milestone-42876.html Wed, 16 May 2012 06:34:00 -0400 https://ca.proactiveinvestors.com/companies/news/35868/angles-computer-game-associate-earns-final-milestone-42876.html ANGLE hails "major breakthrough" in design of Parsortix cancer cell screener https://ca.proactiveinvestors.com/companies/news/35278/angle-hails-major-breakthrough-in-design-of-parsortix-cancer-cell-screener-42100.html Medical diagnostics specialist ANGLE has made what it calls a major breakthrough in the design of the cancer cell screener developed by its Parsortix subsidiary.

]]>
Mon, 30 Apr 2012 07:03:00 -0400 https://ca.proactiveinvestors.com/companies/news/35278/angle-hails-major-breakthrough-in-design-of-parsortix-cancer-cell-screener-42100.html
ANGLE on track for Parsortix launch as it re-positions towards medical diagnostics https://ca.proactiveinvestors.com/companies/news/35179/angle-on-track-for-parsortix-launch-as-it-re-positions-towards-medical-diagnostics-41988.html Thu, 26 Apr 2012 08:57:00 -0400 https://ca.proactiveinvestors.com/companies/news/35179/angle-on-track-for-parsortix-launch-as-it-re-positions-towards-medical-diagnostics-41988.html ANGLE hails another milestone as Parsortix device captures breast cancer cells from patient https://ca.proactiveinvestors.com/companies/news/35009/angle-hails-another-milestone-as-parsortix-device-captures-breast-cancer-cells-from-patient-41772.html Mon, 23 Apr 2012 06:42:00 -0400 https://ca.proactiveinvestors.com/companies/news/35009/angle-hails-another-milestone-as-parsortix-device-captures-breast-cancer-cells-from-patient-41772.html ANGLE's Parsortix screener captures cultured ovarian cancer cells https://ca.proactiveinvestors.com/companies/news/34833/angles-parsortix-screener-captures-cultured-ovarian-cancer-cells-41556.html Tue, 17 Apr 2012 06:33:00 -0400 https://ca.proactiveinvestors.com/companies/news/34833/angles-parsortix-screener-captures-cultured-ovarian-cancer-cells-41556.html ANGLE’s Novocellus starts EmbryoSure clinical trial https://ca.proactiveinvestors.com/companies/news/34652/angles-novocellus-starts-embryosure-clinical-trial-41322.html ANGLE's Novocellus business plans to recruit around 400 patients and the trial is scheduled for completion in mid-year 2013.  Product launch in the UK is anticipated in mid-year 2014.

]]>
Wed, 11 Apr 2012 06:51:00 -0400 https://ca.proactiveinvestors.com/companies/news/34652/angles-novocellus-starts-embryosure-clinical-trial-41322.html
ANGLE portfolio co Geomerics expands its offering https://ca.proactiveinvestors.com/companies/news/34147/angle-portfolio-co-geomerics-expands-its-offering-40705.html Mon, 26 Mar 2012 06:55:00 -0400 https://ca.proactiveinvestors.com/companies/news/34147/angle-portfolio-co-geomerics-expands-its-offering-40705.html ANGLE’s Parsortix device confirmed to detect colon cancer https://ca.proactiveinvestors.com/companies/news/33798/angles-parsortix-device-confirmed-to-detect-colon-cancer--40272.html Thu, 15 Mar 2012 06:46:00 -0400 https://ca.proactiveinvestors.com/companies/news/33798/angles-parsortix-device-confirmed-to-detect-colon-cancer--40272.html ANGLE signs Parsortix research agreement with the Paterson Institute https://ca.proactiveinvestors.com/companies/news/33114/angle-signs-parsortix-research-agreement-with-the-paterson-institute-39438.html Mon, 27 Feb 2012 06:40:00 -0500 https://ca.proactiveinvestors.com/companies/news/33114/angle-signs-parsortix-research-agreement-with-the-paterson-institute-39438.html ANGLE’s Novocellus secures 2nd US patent for IVF test kit https://ca.proactiveinvestors.com/companies/news/32975/angles-novocellus-secures-2nd-us-patent-for-ivf-test-kit--39269.html Wed, 22 Feb 2012 06:50:00 -0500 https://ca.proactiveinvestors.com/companies/news/32975/angles-novocellus-secures-2nd-us-patent-for-ivf-test-kit--39269.html ANGLE's improved deal with Origio and fundraiser kick-start EmbryoSure development https://ca.proactiveinvestors.com/companies/news/32081/angles-improved-deal-with-origio-and-fundraiser-kick-start-embryosure-development-38240.html ANGLE, the intellectual property group, this morning unveiled a new and improved deal to commercialise its potentially revolutionary embryo selection technology for IVF.

]]>
Thu, 26 Jan 2012 06:44:00 -0500 https://ca.proactiveinvestors.com/companies/news/32081/angles-improved-deal-with-origio-and-fundraiser-kick-start-embryosure-development-38240.html
ANGLE hails "tremendous" step forward as Parsortix device separates cancer cells in patient blood https://ca.proactiveinvestors.com/companies/news/31942/angle-hails-tremendous-step-forward-as-parsortix-device-separates-cancer-cells-in-patient-blood-38093.html The potentially revolutionary cancer cell separation device being developed by ANGLE’s subsidiary Parsortix has passed another major milestone by separating cells in blood from an actual patient.

]]>
Mon, 23 Jan 2012 06:54:00 -0500 https://ca.proactiveinvestors.com/companies/news/31942/angle-hails-tremendous-step-forward-as-parsortix-device-separates-cancer-cells-in-patient-blood-38093.html
ANGLE's Parsortix achieves another milestone as separation device captures lung cancer cells https://ca.proactiveinvestors.com/companies/news/30971/angles-parsortix-achieves-another-milestone-as-separation-device-captures-lung-cancer-cells-37048.html ANGLE (LON:AGL) said the potentially revolutionary cell separation device being developed by its Parsortix business has been successful in capturing cultured lung cancer cells.

]]>
Fri, 16 Dec 2011 06:25:00 -0500 https://ca.proactiveinvestors.com/companies/news/30971/angles-parsortix-achieves-another-milestone-as-separation-device-captures-lung-cancer-cells-37048.html
ANGLE signs first research agreement for Parsortix cancer screener https://ca.proactiveinvestors.com/companies/news/30628/angle-signs-first-research-agreement-for-parsortix-cancer-screener-36659.html Wed, 07 Dec 2011 06:38:00 -0500 https://ca.proactiveinvestors.com/companies/news/30628/angle-signs-first-research-agreement-for-parsortix-cancer-screener-36659.html ANGLE plc One2One Investor Presentation - 23rd November 2011 https://ca.proactiveinvestors.com/companies/news/300996/angle-plc-one2one-investor-presentation-23rd-november-2011-0945.html Wed, 23 Nov 2011 08:53:00 -0500 https://ca.proactiveinvestors.com/companies/news/300996/angle-plc-one2one-investor-presentation-23rd-november-2011-0945.html Something for everyone at next Wednesday's Proactive Investors One2One Forum in London: ANGLE, Deltex Medical, Silence Therapeutics and Stanley Gibbons https://ca.proactiveinvestors.com/companies/news/29914/something-for-everyone-at-next-wednesdays-proactive-investors-one2one-forum-in-london-angle-deltex-medical-silence-therapeutics-and-stanley-gibbons-35757.html We have a line-up that offers something for everyone at the Proactive Investors One2One Forum in London next Wednesday 23rd November. ANGLE, whose star really is in the ascendancy, will be joined by Deltex Medical, Silence Therapeutics and Stanley Gibbons

]]>
Thu, 17 Nov 2011 12:33:00 -0500 https://ca.proactiveinvestors.com/companies/news/29914/something-for-everyone-at-next-wednesdays-proactive-investors-one2one-forum-in-london-angle-deltex-medical-silence-therapeutics-and-stanley-gibbons-35757.html
ANGLE to review options for EmbryoSure trials at end of November https://ca.proactiveinvestors.com/companies/news/29841/angle-to-review-options-for-embryosure-trials-at-end-of-november-35669.html Wed, 16 Nov 2011 06:26:00 -0500 https://ca.proactiveinvestors.com/companies/news/29841/angle-to-review-options-for-embryosure-trials-at-end-of-november-35669.html ANGLE says Parsortix screening device captures prostate cancer cells https://ca.proactiveinvestors.com/companies/news/29686/angle-says-parsortix-screening-device-captures-prostate-cancer-cells--35498.html ANGLE's medical diagnostics business, Parsortix, has made another important breakthrough, it was revealed today. Its cell separation device can capture prostate cancer cells.

]]>
Fri, 11 Nov 2011 07:02:00 -0500 https://ca.proactiveinvestors.com/companies/news/29686/angle-says-parsortix-screening-device-captures-prostate-cancer-cells--35498.html
ANGLE's cancer screening device excites the market, but it is only part of the story https://ca.proactiveinvestors.com/companies/news/29439/angles-cancer-screening-device-excites-the-market-but-it-is-only-part-of-the-story-35203.html ANGLE is the longest established of the intellectual property groups quoted on the London market. The share price rocketed recently when the group revealed Parsortix, one of its companies, had successfully tested a blood screening device that could change forever the way cancer is treated and monitored. But there is more to the group than just this one business. Proactive Investors spoke to chief executive Andrew Newland to find out more.

 

]]>
Fri, 04 Nov 2011 08:56:00 -0400 https://ca.proactiveinvestors.com/companies/news/29439/angles-cancer-screening-device-excites-the-market-but-it-is-only-part-of-the-story-35203.html
Angle says Geomerics software business has made "significant progress on a number of fronts" https://ca.proactiveinvestors.com/companies/news/29036/angle-says-geomerics-software-business-has-made-significant-progress-on-a-number-of-fronts-34705.html Mon, 24 Oct 2011 08:09:00 -0400 https://ca.proactiveinvestors.com/companies/news/29036/angle-says-geomerics-software-business-has-made-significant-progress-on-a-number-of-fronts-34705.html Angle chief bullish about prospects for cancer detection device https://ca.proactiveinvestors.com/companies/news/28534/angle-chief-bullish-about-prospects-for-cancer-detection-device-34096.html The technology group Angle this morning gave an incredibly bullish assessment of the prospects for the cell separation device developed by the company’s Parsortix business. In a conference call chief executive Andrew Newland revealed it is already “in dialogue” with major medical device manufacturers as it looks to realise the technology’s potential.

 

]]>
Fri, 07 Oct 2011 13:29:00 -0400 https://ca.proactiveinvestors.com/companies/news/28534/angle-chief-bullish-about-prospects-for-cancer-detection-device-34096.html
Wellcome Trust to provide further £3.8m to ANGLE’s 25% owned NeuroTargets https://ca.proactiveinvestors.com/companies/news/15660/wellcome-trust-to-provide-further-38m-to-angles-25-owned-neurotargets-18927.html Fri, 16 Jul 2010 12:17:00 -0400 https://ca.proactiveinvestors.com/companies/news/15660/wellcome-trust-to-provide-further-38m-to-angles-25-owned-neurotargets-18927.html